World News

The agreement builds on Haleon’s existing use of Microsoft 365 Copilot and broadens the company’s adoption of Microsoft’s AI, cloud and data technologies.

Tregzi, also known as Orca-T, is an engineered allogeneic cell therapy used alongside matched-donor hematopoietic stem cell transplantation.

The expanded label is expected to make about 5,500 additional children in the United States eligible for treatment.

The acquisition centres on potravitug, a Phase II monoclonal antibody developed to treat BK polyomavirus-associated nephropathy (BKPyVAN).

The acquisition gives Zimmer Biomet full ownership of the iovera° system, an FDA-cleared medical device that relieves pain without medication.

The OPUSWAVE Imaging System is built around Terumo’s DualView Imaging Catheter, which combines optical frequency-domain imaging (OFDI) and intravascular ultrasound (IVUS) on a single platform.

The company has announced plans to expand its antibody-drug conjugate (ADC) manufacturing capabilities in Switzerland while also broadening its long-term partnership with a leading, though undisclosed, U.S.-based biopharmaceutical company.

The collaboration aims to turn scientific discoveries into practical healthcare solutions by combining MIT’s research expertise with Abu Dhabi’s expanding life sciences ecosystem.

The initiative brings together SK bioscience, global health nonprofit PATH, consulting firm Slalom and technology partner SK AX to create an evidence-based system that helps researchers evaluate vaccine candidates before they enter costly late-stage clinical trials.

The combined business will operate as Cortigent Holdings and trade on Nasdaq under the ticker symbol CRGT once the transaction closes, expected in the third quarter of 2026, subject to shareholder and regulatory approvals.